BioCentury | Jun 21, 2017
Company News

Management tracks

...Griffin CFO. He was VP of finance at Entellus Medical Inc. (NASDAQ:ENTL). Urology play Aytu BioScience Inc. (OTCQX:AYTU...
BioCentury | Jan 6, 2017
Finance

Good riddance

...$42.0 $276.8 $193.8 -30% Xenetic Biosciences Inc. (NASDAQ:XBIO) (A) 11/1/16 $10.0 NA $35.6 NA Aytu BioScience Inc. (OTCQX:AYTU...
BioCentury | Sep 26, 2016
Financial News

Aytu proposes follow-on

...Aytu BioScience Inc. (OTCQX:AYTU), Englewood, Colo. Business: Genitourinary Date announced: 2016-09-21 Type: Follow-on To be raised...
...$14.4 million Shares: TBD Price prior: $3.50 Underwriters: Joseph Gunnar; Feltl; Fordham Financial Management Note: Aytu...
BioCentury | Aug 1, 2016
Financial News

Aytu completes private placement

...Aytu BioScience Inc. (OTCQX:AYTU), Englewood, Colo. Business: Genitourinary Date completed: 2016-07-28 Type: Private placement Raised: $500,000...
BioCentury | Jul 11, 2016
Finance

Ground up

...NASDAQ:VTGN) 5/10/16 $10.9 $33.7 $31.1 -8% Neuralstem Inc. (NASDAQ:CUR) 5/3/16 $8.0 $44.8 $33.3 -35% Aytu BioScience Inc. (OTCQX:AYTU...
BioCentury | May 9, 2016
Company News

Acerus Pharmaceuticals, Aytu deal

...Acerus (formerly Trimel Pharmaceuticals Corp. ) granted Aytu exclusive, U.S. marketing rights to testosterone replacement therapy...
...distribute Natesto in the U.S. until June 30. Acerus Pharmaceuticals Corp. (TSX:ASP), Mississauga, Ontario Aytu BioScience Inc. (OTCQX:AYTU...
BioCentury | May 9, 2016
Financial News

Aytu completes follow-on

...Aytu BioScience Inc. (OTCQX:AYTU), Englewood, Colo. Business: Genitourinary Date completed: 2016-05-02 Type: Follow-on Raised: $7.5 million...
BioCentury | May 2, 2016
Financial News

Aytu amends follow-on

...Aytu BioScience Inc. (OTCQX:AYTU), Englewood, Colo. Business: Genitourinary Date announced: 2016-04-25 Type: Follow-on To be raised...
...be raised: TBD Shares: TBD Price prior: $0.69 Underwriters: Joseph Gunnar; Fordham Financial Management Note: Aytu...
BioCentury | May 2, 2016
Financial News

Acerus Pharmaceuticals completes private placement

...C$2.5 million ($2 million) Shares: 12.2 million Price: C$0.21 Shares after offering: 213.1 million Investor: Aytu BioScience Inc. WIR...
BioCentury | Apr 11, 2016
Company News

Aytu, Allegis deal

...rights to co-promote Primsol trimethoprim in the U.S. Allegis will promote the drug to pediatricians; Aytu...
...age. Aytu declined to disclose financial details, and Allegis did not respond to inquiries. Aytu BioScience Inc. (OTCQX:AYTU...
Items per page:
1 - 10 of 14
BioCentury | Jun 21, 2017
Company News

Management tracks

...Griffin CFO. He was VP of finance at Entellus Medical Inc. (NASDAQ:ENTL). Urology play Aytu BioScience Inc. (OTCQX:AYTU...
BioCentury | Jan 6, 2017
Finance

Good riddance

...$42.0 $276.8 $193.8 -30% Xenetic Biosciences Inc. (NASDAQ:XBIO) (A) 11/1/16 $10.0 NA $35.6 NA Aytu BioScience Inc. (OTCQX:AYTU...
BioCentury | Sep 26, 2016
Financial News

Aytu proposes follow-on

...Aytu BioScience Inc. (OTCQX:AYTU), Englewood, Colo. Business: Genitourinary Date announced: 2016-09-21 Type: Follow-on To be raised...
...$14.4 million Shares: TBD Price prior: $3.50 Underwriters: Joseph Gunnar; Feltl; Fordham Financial Management Note: Aytu...
BioCentury | Aug 1, 2016
Financial News

Aytu completes private placement

...Aytu BioScience Inc. (OTCQX:AYTU), Englewood, Colo. Business: Genitourinary Date completed: 2016-07-28 Type: Private placement Raised: $500,000...
BioCentury | Jul 11, 2016
Finance

Ground up

...NASDAQ:VTGN) 5/10/16 $10.9 $33.7 $31.1 -8% Neuralstem Inc. (NASDAQ:CUR) 5/3/16 $8.0 $44.8 $33.3 -35% Aytu BioScience Inc. (OTCQX:AYTU...
BioCentury | May 9, 2016
Company News

Acerus Pharmaceuticals, Aytu deal

...Acerus (formerly Trimel Pharmaceuticals Corp. ) granted Aytu exclusive, U.S. marketing rights to testosterone replacement therapy...
...distribute Natesto in the U.S. until June 30. Acerus Pharmaceuticals Corp. (TSX:ASP), Mississauga, Ontario Aytu BioScience Inc. (OTCQX:AYTU...
BioCentury | May 9, 2016
Financial News

Aytu completes follow-on

...Aytu BioScience Inc. (OTCQX:AYTU), Englewood, Colo. Business: Genitourinary Date completed: 2016-05-02 Type: Follow-on Raised: $7.5 million...
BioCentury | May 2, 2016
Financial News

Aytu amends follow-on

...Aytu BioScience Inc. (OTCQX:AYTU), Englewood, Colo. Business: Genitourinary Date announced: 2016-04-25 Type: Follow-on To be raised...
...be raised: TBD Shares: TBD Price prior: $0.69 Underwriters: Joseph Gunnar; Fordham Financial Management Note: Aytu...
BioCentury | May 2, 2016
Financial News

Acerus Pharmaceuticals completes private placement

...C$2.5 million ($2 million) Shares: 12.2 million Price: C$0.21 Shares after offering: 213.1 million Investor: Aytu BioScience Inc. WIR...
BioCentury | Apr 11, 2016
Company News

Aytu, Allegis deal

...rights to co-promote Primsol trimethoprim in the U.S. Allegis will promote the drug to pediatricians; Aytu...
...age. Aytu declined to disclose financial details, and Allegis did not respond to inquiries. Aytu BioScience Inc. (OTCQX:AYTU...
Items per page:
1 - 10 of 14